Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · Real-Time Price · USD

4.220

-0.210 (-4.74%)

Feb 19, 2026, 11:21 AM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Developing and Commercializing Therapeutics	128.94M	8.57M	63.57M	20.34M	-
Developing and Commercializing Therapeutics Growth	1404.02%	-86.51%	212.55%	-	-
Total	128.94M	8.57M	63.57M	20.34M	-
Total Growth	1404.02%	-86.51%	212.55%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	128.94M	8.57M	63.57M	20.34M	-
United States Growth	1404.02%	-86.51%	212.55%	-	-
Total	128.94M	8.57M	63.57M	20.34M	-
Total Growth	1404.02%	-86.51%	212.55%	-	-

Source: S&P Global Market Intelligence.